Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.600
-0.060 (-1.29%)
Aug 21, 2026, 9:46 AM EDT - Market open
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $597.92 million as of August 21, 2026. Its market cap has increased by 17.49% in one year.
Market Cap
597.92M
Enterprise Value
362.38M
1-Year Change
17.49%
Ranking
Category
Stock Price
$4.60
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $597.92M, a decrease of -73.55%. That is a compound annual growth rate of -23.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 597.92M | -7.40% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Varex Imaging | 778.05M |
| AdaptHealth | 776.44M |
| SS Innovations International | 743.43M |
| OrthoPediatrics | 665.80M |
| BrainsWay | 595.24M |
| Delcath Systems | 585.02M |
| Cerus | 556.21M |
| Tactile Systems Technology | 540.26M |